These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 24747176
1. Transcriptional regulation of the human thromboxane A2 receptor gene by Wilms' tumor (WT)1 and hypermethylated in cancer (HIC) 1 in prostate and breast cancers. Keating GL, Reid HM, Eivers SB, Mulvaney EP, Kinsella BT. Biochim Biophys Acta; 2014 Jun; 1839(6):476-92. PubMed ID: 24747176 [Abstract] [Full Text] [Related]
2. Regulated expression of the TPβ isoform of the human T prostanoid receptor by the tumour suppressors FOXP1 and NKX3.1: Implications for the role of thromboxane in prostate cancer. O'Sullivan AG, Eivers SB, Mulvaney EP, Kinsella BT. Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3153-3169. PubMed ID: 28890397 [Abstract] [Full Text] [Related]
3. The Wilms' tumour suppressor protein WT1 acts as a key transcriptional repressor of the human thromboxane A2 receptor gene in megakaryocytes. Gannon AM, Kinsella BT. J Cell Mol Med; 2009 Dec; 13(11-12):4571-86. PubMed ID: 19067769 [Abstract] [Full Text] [Related]
4. Differential expression of the TPα and TPβ isoforms of the human T Prostanoid receptor during chronic inflammation of the prostate: Role for FOXP1 in the transcriptional regulation of TPβ during monocyte-macrophage differentiation. Mulvaney EP, O'Sullivan ÁG, Eivers SB, Reid HM, Kinsella BT. Exp Mol Pathol; 2019 Oct; 110():104277. PubMed ID: 31271729 [Abstract] [Full Text] [Related]
5. Regulated expression of the alpha isoform of the human thromboxane A2 receptor during megakaryocyte differentiation: a coordinated role for WT1, Egr1, and Sp1. Gannon AM, Turner EC, Reid HM, Kinsella BT. J Mol Biol; 2009 Nov 20; 394(1):29-45. PubMed ID: 19747485 [Abstract] [Full Text] [Related]
6. van den Heuvel-Eibrink MM, Kinsella BT. ; 2016 03 20. PubMed ID: 27512756 [Abstract] [Full Text] [Related]
7. Expression of the TPα and TPβ isoforms of the thromboxane prostanoid receptor (TP) in prostate cancer: clinical significance and diagnostic potential. Mulvaney EP, Shilling C, Eivers SB, Perry AS, Bjartell A, Kay EW, Watson RW, Kinsella BT. Oncotarget; 2016 Nov 08; 7(45):73171-73187. PubMed ID: 27689401 [Abstract] [Full Text] [Related]
8. Protein kinase C-related kinase 1 and 2 play an essential role in thromboxane-mediated neoplastic responses in prostate cancer. O'Sullivan AG, Mulvaney EP, Hyland PB, Kinsella BT. Oncotarget; 2015 Sep 22; 6(28):26437-56. PubMed ID: 26296974 [Abstract] [Full Text] [Related]
9. Synthetic peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone suppress transcription by promoter 3 of the human thromboxane A2 receptor gene in human erythroleukemia cells. Coyle AT, Kinsella BT. Biochem Pharmacol; 2006 Apr 28; 71(9):1308-23. PubMed ID: 16499875 [Abstract] [Full Text] [Related]
10. 15-deoxy Delta12,14-prostaglandin J2 suppresses transcription by promoter 3 of the human thromboxane A2 receptor gene through peroxisome proliferator-activated receptor gamma in human erythroleukemia cells. Coyle AT, O'Keeffe MB, Kinsella BT. FEBS J; 2005 Sep 28; 272(18):4754-73. PubMed ID: 16156795 [Abstract] [Full Text] [Related]
11. Regulation of protein kinase C-related kinase (PRK) signalling by the TPα and TPβ isoforms of the human thromboxane A2 receptor: Implications for thromboxane- and androgen- dependent neoplastic and epigenetic responses in prostate cancer. O'Sullivan AG, Mulvaney EP, Kinsella BT. Biochim Biophys Acta Mol Basis Dis; 2017 Apr 28; 1863(4):838-856. PubMed ID: 28108419 [Abstract] [Full Text] [Related]
12. Regulation of the human thromboxane A2 receptor gene by Sp1, Egr1, NF-E2, GATA-1, and Ets-1 in megakaryocytes. Gannon AM, Kinsella BT. J Lipid Res; 2008 Dec 28; 49(12):2590-604. PubMed ID: 18698092 [Abstract] [Full Text] [Related]
13. Identification of an interaction between the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor with protein kinase C-related kinase (PRK) 1: implications for prostate cancer. Turner EC, Kavanagh DJ, Mulvaney EP, McLean C, Wikström K, Reid HM, Kinsella BT. J Biol Chem; 2011 Apr 29; 286(17):15440-57. PubMed ID: 21357687 [Abstract] [Full Text] [Related]
14. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1. Zaia A, Fraizer GC, Piantanelli L, Saunders GF. Anticancer Res; 2001 Apr 29; 21(1A):1-10. PubMed ID: 11299720 [Abstract] [Full Text] [Related]
15. Characterization of promoter 3 of the human thromboxane A receptor gene. A functional AP-1 and octamer motif are required for basal promoter activity. Coyle AT, Kinsella BT. FEBS J; 2005 Feb 29; 272(4):1036-53. PubMed ID: 15691336 [Abstract] [Full Text] [Related]
16. Correlation of Wilms' tumor 1 isoforms with HER2 and ER-α and its oncogenic role in breast cancer. Nasomyon T, Samphao S, Sangkhathat S, Mahattanobon S, Graidist P. Anticancer Res; 2014 Mar 29; 34(3):1333-42. PubMed ID: 24596380 [Abstract] [Full Text] [Related]
17. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells. Han Y, San-Marina S, Yang L, Khoury H, Minden MD. Breast Cancer Res; 2007 Mar 29; 9(4):R43. PubMed ID: 17634147 [Abstract] [Full Text] [Related]
18. The Wilms' tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells. Brett A, Pandey S, Fraizer G. Mol Cancer; 2013 Jan 08; 12():3. PubMed ID: 23298185 [Abstract] [Full Text] [Related]
19. Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells. Vidovic K, Svensson E, Nilsson B, Thuresson B, Olofsson T, Lennartsson A, Gullberg U. Leukemia; 2010 May 08; 24(5):992-1000. PubMed ID: 20237505 [Abstract] [Full Text] [Related]
20. Endoplasmic reticulum stress induces PRNP prion protein gene expression in breast cancer. Déry MA, Jodoin J, Ursini-Siegel J, Aleynikova O, Ferrario C, Hassan S, Basik M, LeBlanc AC. Breast Cancer Res; 2013 Mar 12; 15(2):R22. PubMed ID: 23497519 [Abstract] [Full Text] [Related] Page: [Next] [New Search]